Roivant Sciences

New York, United States

Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.

Feb 2023

Post-IPO Equity

Biopharma Biotechnology Health Care Pharmaceutical Product Research

Top Investors

Founders FundPatient Square CapitalFidelityRTW InvestmentsPalantir Technologies

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Roivant Sciences

Who are Roivant Sciences's investors?

Roivant Sciences's investors include Founders Fund, Patient Square Capital, Fidelity, RTW Investments, Palantir Technologies.

Where is Roivant Sciences headquartered?

Roivant Sciences is headquartered in New York, United States.

What does Roivant Sciences do?

Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.

What stage is Roivant Sciences at?

Roivant Sciences is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 2, 2023.

MLA

"Roivant Sciences — Funding & Investors." VCBacked, February 2, 2023, https://www.vcbacked.co/company/roivant-sciences. Accessed July 1, 2026.

APA

VCBacked. (2023). Roivant Sciences — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/roivant-sciences

Wikipedia (cite web)

{{cite web |title=Roivant Sciences — Funding & Investors |url=https://www.vcbacked.co/company/roivant-sciences |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 2, 2023.

Similar Companies in Biopharma

View all

Living In Silico Inc.

Crystalys Therapeutics

San Diego

ARS Pharmaceuticals

San Diego